The influence of anti-Mullerian hormone on folliculogenesis;Wpływ hormonu anty-mullerowskiego (AMH) na folikulogeneze

Ginekologia Polska

Volumn 79, Issue 2, 2008, Pages 137-140

  Skałba, Piotr ^a   Cygal, Anna ^a   Dabkowska Hué, Anna ^a  

^a Klinika Po oznictwa i Ginekologii LAM   (Poland)

Author keywords

Anti mullerian hormone; Ovary polycystric ovary syndrome

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

BLOOD; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MENSTRUAL CYCLE; OVARY; OVARY FOLLICLE; OVULATION; OVULATION INDUCTION; PHYSIOLOGY; REVIEW; SECRETION;

ANTI-MULLERIAN HORMONE; FEMALE; HUMANS; MENSTRUAL CYCLE; OVARIAN FOLLICLE; OVARY; OVULATION; OVULATION INDUCTION;

EID: 45549086183     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990, 6, 597-641.
2. Jarmińska-Jackowiak T, Warenik-Szymankiewicz A, Trzeciak W. Hormon antymullerowski. Struktura i rola w różnicowaniu płci. Ginekol Pol. 1995, 66, 51-58.
3. Gouédard L, Chen Y, Thevenet L. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J Biol Chem. 2000, 275, 27973-27978.
4. Baarends W, van Helmond M, Post M, [et al.]. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. Development. 1994, 120, 189-197.
5. di Clemente N, Wilson C, Faure E, [et al.]. Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol Endocrinol. 1994, 8, 1006-1020.
6. Mishina Y, Rey R, Finegold M, [et al.]. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 1996, 10, 2577-2587.
7. Imbeaud S, Faure E, Lamarre I, [et al.]. Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor. Nat Genet. 1995, 11, 382-388.
8. Tsuji M, Shima H, Yonemura C. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat. Endocrinology. 1992, 131, 1481-1488.
9. Wrana J, Attisano L. The Smad pathway. Cytokine Growth Factor Rev. 2000, 11, 5-13.
10. Gouédard L, Chen Y, Thevenet L, [et al.]. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J Biol Chem. 2000, 275, 27973-27978.
11. Heldin C, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997, 390, 465-471.
12. Durlinger A, Visser J, Themmen A. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002, 124, 601-609.
13. Josso N, Lamarre I, Picard J, [et al.]. Anti-müllerian hormone in early human development. Early Hum Dev. 1993, 33, 91-99.
14. Baarends W, Uilenbroek J, Kramer P, [et al.]. Anti-Mullerian hormone type II receptor messanger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 1995, 136, 4951-4962.
15. Weenen C, Laven J, Von Bergh A, [et al.]. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004, 10, 77-83.
16. Skałba P. Endokrynologia ginekologiczna. Warszawa: PZWL, 1998.
17. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod. 1986, 1, 81-87.
18. Franchin R, Schonauer L, Righini C, [et al.]. Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Human Reprod. 2003, 18, 328-332.
19. Josso N, Racine C, di Clemente N, [et al.]. The role of anti-Mullerian hormone in gonadal development. Mol Cell Endocrinol. 1998, 145, 3-7.
20. Behringer R, Cate R, Froelick G, [et al.]. Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance. Nature. 1990, 345, 167-170.
21. Durlinger A, Kramer P, Karels B, [et al.]. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology. 1999, 140, 5789-5796.
22. Durlinger A, Gruijters M, Kramer P, [et al.]. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002, 143, 1076-1084.
23. Durlinger A, Gruijters M, Kramer P, [et al.]. Anti-Mullerian hormone attenuates the effect of FSH on follicle development in the mouse ovary. Endocrinology. 2001, 142, 4891-4899.
24. Pigny P, Merlen E, Robert Y, [et al.]. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003, 88, 5957-5962.
25. Laven J, Mulders A, Visser J. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004, 89, 318-323.
26. Moran L, Noakes M, Clifton P, [et al.]. The use of anti-mullerian hormone in predicting menstrual response following weight loss in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007, 92, 3796-3802.
27. Piltonen T, Morin-Papunen L, Koivunen R, et al.. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod. 2005, 20, 1820-1826.
28. de Vet A, Laven J, de Jong F, [et al.]. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002, 77, 357-362.
29. van Rooij I, Broekmans F, te Velde E, [et al.]. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002, 17, 3065-3071.
30. Bath L, Wallace W, Shaw M, [et al.]. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003, 18, 2368-2374.